Hem › Triplenegativ bröstcancer › Oregon › Portland
Kliniska studier för Triplenegativ bröstcancer i Portland, OR
9 studier för Triplenegativ bröstcancer söker deltagare vid platser i och runt Portland (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekryterarFas 1/2
- Oregon Health & Science University (OHSU), Portland
Study of AVZO-021 in Patients With Advanced Solid Tumors
RekryterarFas 1/2
- Avenzo Therapeutics Recruiting Site, Portland
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
RekryterarFas 3
- Providence Portland Medical Center ( Site 0116), Portland
- Providence Oncology and Hematology Care Clinic - Westside ( Site 0126), Portland
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
RekryterarFas 1/2
- Providence Portland Medical Center, Portland
- Providence St. Vincent Medical Center, Portland
- Local Institution - 0052, Portland
Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients
RekryterarFas 2
- Providence Portland Cancer Institute - Franz Clinic, Portland
- Providence St. Vincent Medical Center, Portland
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
RekryterarFas 3
- Oregon Health & Science University, Portland
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
RekryterarFas 1/2
- Providence Cancer Center Oncology and Hematology Care- Eastside, Portland
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekryterarFas 1/2
- Compass Oncology - Rose Quarter, Portland
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekryterarFas 2
- Oregon Health & Science Institute (OHSU), Portland
Triplenegativ bröstcancer-studier i andra städer
- Houston, TX42 studier
- New York City, NY31 studier
- Nashville, TN28 studier
- Los Angeles, CA27 studier
- Boston, MA26 studier
- San Antonio, TX23 studier
- St. Louis, MO21 studier
- Arlington, VA20 studier
- Atlanta, GA20 studier
- Dallas, TX18 studier
- Chicago, IL16 studier
- Columbus, OH16 studier
Andra studier i Portland
- Icke-småcellig lungcancer46 studier
- Cancer (alla typer)34 studier
- Bröstcancer33 studier
- Prostatacancer33 studier
- Metastaserande cancer29 studier
- Kolorektal cancer28 studier
- Äggstockscancer27 studier
- Lungcancer26 studier
- Akut myeloid leukemi25 studier
- Endometriecancer24 studier
- Plattenepitelcancer i huvud och hals19 studier
- Bukspottkörtelcancer19 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.